To: Spark who wrote (878 ) 6/8/1999 2:05:00 PM From: Spark Read Replies (1) | Respond to of 1692
I was complaining about VRDE's lack of news the other day..they must have heard me..LOL Ready to Debut in Major Drug Store Chains ST. PETERSBURG, Fla.--(BUSINESS WIRE)--June 8, 1999--Veridien Corporation (OTC BB:VRDE - news), announced that Veridien's VIRAGUARD(r) family of products (bactericides, virucides, and fungicides) is soon to be carried on the shelves of national and regional drugstore chains. Veridien Corporation's Canadian Licensee, Backcourt Industries, Inc., expects that in 4 - 6 weeks Veridien's VIRAGUARD(r) products will be added to the shelves of over 800 Canadian drugstores. This will ensure the availability of VIRAGUARD(r) products in every significant urban center across Canada. Coinciding with the introduction of the VIRAGUARD(r) products to the Canadian retail market, a national sampling program through Chum Radio Network (TSE:CHM - news) has been arranged for the summer. Chum Limited is one of the premiere broadcasting groups in North America. Their programming line-up is highlighted by a number of successful syndicated shows including The Dr. Laura Schlessinger Show, The Dr. Joy Browne Show, The Dr. Gabe Mirkin Show, and Bob Vila's ''HouseSense''. CHUM also owns Major League Baseball games radio broadcast rights in Toronto. Other partners participating in the national promotion program includes Imperial Oil (Esso) ((TSE:IMO - news) and Parent Company Exxon Corporation (NYSE: XON - news)), Volvo (subsidiary of Ford Motor Company (NYSE:F - news) and Via Rail Canada (TSE:CNR - news). Additional advertising for the VIRAGUARD(r) family of products is planned for this summer through television spots on Headline Sports and radio spots during broadcasts of Major League Baseball games. Mr. Bob Crago of A.S. May Powell Corporation, a lead broker for VIRAGUARD(r) products in Canada, stated ''We have been working with Veridien Corporation and Backcourt Industries, Inc. for over six months in launching Veridien's VIRAGUARD(r) products to the retail market. We are excited about the prospects for a unique family of antimicrobial products such as VIRAGUARD(r) being listed with a major national drugstore chain. VIRAGUARD(r) products will soon be the recognized brand for personal protection against germs for families.'' ABOUT THE COMPANY Veridien Corporation is a Health Care Products Company that has developed unique infection control products including patented disinfectants, antiseptics, skin cleansers and sterilants. These products are inherently non-toxic, and are environmentally friendly. The flagship product VIRAHOL(r) is a patented, EPA registered, surface disinfectant, environmentally friendly and nontoxic by OSHA Standard 29 CFR 1910.1200. Additional Veridien products include VIRAGEL(r), an FDA regulated antiseptic hand gel and VIRAGUARD(r) FIRST AID an FDA regulated first aid antiseptic spray. Veridien's product line is currently sold nationally through dental and medical distributors including Allegiance Healthcare, a spin-off of Baxter, Darby Dental, Henry Schein (HSIC), HSP, Inc. - Health Science Products, McKesson General Medical, and Patterson Dental. Veridien's products are also distributed under private label to the network marketing industry ie: Nutrition for Life International (NFLI). Veridien is currently looking to expand sales to nationally known retail drug market chains and through E-Commerce. TOMORROW'S INFECTION CONTROL PRODUCTS FOR TODAY Look for us at businesswire.com Special Note: Forward-looking statements in this press release are made pursuant to the ''safe-harbor'' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements. Contact: Investor Relations: PMR and Associates